Identification of hub genes in bladder transitional cell carcinoma through ceRNA network construction integrated with gene network analysis

Abstract

AbstractBladder transitional cell carcinoma (BTCC) forms more than 90% of bladder cancer cases. It brings challenges to the early diagnosis and therapy of BTCC, due to lack of efficient screening biomarkers. We used weighted gene co‐expression network analysis (WGCNA) combined competing endogenous RNA (ceRNA) network construction depending on TCGA datasets to investigate potential hub genes and regulatory pathways associated with occurrence and progression of BTCC. We further used real‐time polymerase chain reaction (RT‐PCR) to validate the relative expression genes correlated with BTCC. By WGCNA, the gene co‐expression module with 11 genes was found corelated with BTCC tumour stage and prognosis after survival analyses. Ultimately, we put 100 highly stage‐related genes into the above constructed ceRNA network and then constructed another new network. Among them, all elements in AC112721.1/LINC00473/AC128709.1‐hsa‐mir‐195‐RECK and LINC00460‐hsa‐mir‐429‐ZFPM2 axes were simultaneously corelated with overall survival. RT‐PCR showed that AKAP12 was downregulated in tumour tissues. The hub genes screened out in the present study may provide ideals for further treatment on BTCC.